SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder that’s both progressive and incurable. But now, nerve specialists ...
Mitochondria In Motion Inc. has identified new N-(trans-4-hydroxycyclohexyl)-6-phenylhexanamide derivatives acting as mitofusin activators and reported to be useful for the treatment of Alzheimer’s, ...
The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor in the Department of Human Genetics at the University of Utah. These grants ...
and an estimated one million individuals with an inherited degenerative nerve condition called Charcot–Marie–Tooth disease type 2 (CMT2). Peripheral neuropathy can cause severe disability and ...
A group of inherited disorders which cause nerve damage mostly ... Other laboratory tests to confirm the condition. Treatments can help manage condition, no known cure Diagnosed by medical ...
Miralinc Pharma Inc. has patented new heterocyclic selective histone deacetylase 6 (HDAC6) inhibitors reported to be useful for the treatment of type 2 Charcot-Marie-Tooth disease and ...
Treatment with CKD-510 restored the shortened ... including the application to neurodegenerative diseases such as Charcot-Marie-Tooth disease (CMT) 1, 2. The axonal transport of intracellular ...
This tests how your brain and nervous system are functioning. Your treatment will depend on the type of circadian rhythm disorder and its cause. The goal is to adjust your sleep pattern to fit ...
Bipolar disorder can lead to risky behavior, damaged relationships and careers, and even suicidal tendencies if it's not treated. Doctors don't completely understand the causes of bipolar disorder.